Holen Sie sich die Stockscreener-App
13.46
7.34%
0.92
Handel nachbörslich:
13.23
-0.23
-1.71%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$12.54
Offen:
$13.235
24-Stunden-Volumen:
810.81K
Relative Volume:
1.15
Marktkapitalisierung:
$613.02M
Einnahmen:
$159.01M
Nettoeinkommen (Verlust:
$-21.72M
KGV:
-25.88
EPS:
-0.52
Netto-Cashflow:
$-20.63M
1W Leistung:
+13.87%
1M Leistung:
+37.49%
6M Leistung:
-28.02%
1J Leistung:
+42.43%
1-Tages-Spanne:
$13.20
$13.65
1-Wochen-Bereich:
$11.25
$13.65
52-Wochen-Spanne:
$7.34
$21.00
Axogen Inc Stock (AXGN) Company Profile
Firmenname
Axogen Inc
Sektor
Branche
Telefon
(386) 462-6817
Adresse
13631 PROGRESS BLVD., ALACHUA, FL
Vergleichen Sie AXGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AXGN
Axogen Inc
|
13.46 | 571.12M | 159.01M | -21.72M | -20.63M | -0.52 |
|
ABT
Abbott Laboratories
|
125.83 | 218.75B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.76 | 152.62B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
400.93 | 151.01B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
92.01 | 117.43B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.91 | 44.76B | 5.54B | 4.18B | 623.10M | 7.00 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-17 | Eingeleitet | Lake Street | Buy |
| 2024-07-01 | Eingeleitet | Raymond James | Outperform |
| 2022-11-11 | Fortgesetzt | Jefferies | Buy |
| 2022-05-09 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2022-03-11 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-10-23 | Eingeleitet | Guggenheim | Buy |
| 2020-06-16 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-05-07 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2020-04-02 | Herabstufung | BTIG Research | Buy → Neutral |
| 2019-08-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-07-12 | Eingeleitet | Canaccord Genuity | Buy |
| 2018-03-02 | Bestätigt | Lake Street | Buy |
| 2018-01-05 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2017-11-30 | Eingeleitet | Jefferies | Buy |
| 2017-11-21 | Bestätigt | Lake Street | Buy |
| 2017-07-31 | Eingeleitet | Leerink Partners | Outperform |
| 2017-06-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-03-06 | Eingeleitet | ROTH Capital | Buy |
| 2016-11-22 | Hochstufung | Lake Street | Hold → Buy |
| 2016-11-07 | Bestätigt | Wedbush | Outperform |
| 2016-11-03 | Herabstufung | Lake Street | Buy → Hold |
| 2016-08-04 | Bestätigt | Wedbush | Outperform |
| 2014-05-14 | Eingeleitet | Dawson James | Buy |
| 2013-10-31 | Bestätigt | Ladenburg Thalmann | Buy |
Alle ansehen
Axogen Inc Aktie (AXGN) Neueste Nachrichten
Axogen, Inc.'s (NASDAQ:AXGN) Shares Leap 29% Yet They're Still Not Telling The Full Story - simplywall.st
Axogen Inc. Stock Analysis and ForecastHigh-profit trading signals - Autocar Professional
Axogen, Inc. to report 2025 second quarter financial results on August 5, 2025 - GlobeNewswire
Arizona State Retirement System Makes New $222,000 Investment in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Is Axogen Inc. a good long term investmentExtraordinary profit generation - jammulinksnews.com
Axogen, Inc. to Announce 2025 Second Quarter Financial Results on August 5, 2025 - Quiver Quantitative
What analysts say about Axogen Inc. stockAccelerated investment success - jammulinksnews.com
Why Axogen Inc. stock attracts strong analyst attentionFree AI-Powered Stock Predictions - Newser
What drives Axogen Inc. stock pricePhenomenal investment performance - jammulinksnews.com
Leerink Partnrs Brokers Lower Earnings Estimates for AxoGen - Defense World
Leerink Partnrs Has Pessimistic View of AxoGen Q4 Earnings - Defense World
why axogen inc. stock attracts strong analyst attentionRisk Aware High Growth Picks - Newser
How Axogen Inc. stock performs during market volatilityFree Premium Stock Market Reports - Newser
What makes Axogen Inc. stock price move sharplyInvestor Favorite Picks - Newser
How To Trade (AXGN) - news.stocktradersdaily.com
Axogen (NASDAQ:AXGN) swells 10% this week, taking three-year gains to 46% - simplywall.st
AxoGen’s SWOT analysis: nerve repair leader’s stock poised for growth By Investing.com - Investing.com India
Learn to Evaluate (AXGN) using the Charts - news.stocktradersdaily.com
Axogen Showcases Nerve Repair Vision at Goldman Sachs - Yahoo Finance
Axogen, Inc. (NASDAQ:AXGN) Is Expected To Breakeven In The Near Future - 富途牛牛
15 Best Growth Stocks to Invest in for the Next 5 Years - Insider Monkey
Long Term Trading Analysis for (AXGN) - news.stocktradersdaily.com
SG Americas Securities LLC Has $704,000 Holdings in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
AxoGen, Inc. (NASDAQ:AXGN) Shares Bought by Rhumbline Advisers - Defense World
Institutional investors in Axogen, Inc. (NASDAQ:AXGN) see US$53m decrease in market cap last week, although long-term gains have benefitted them. - simplywall.st
Axogen Announces Appointment of Jesse Bishop as Vice President of Regulatory Affairs and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Globe and Mail
AxoGen at Goldman Sachs Conference: Strategic Path to Nerve Repair Growth - Investing.com Canada
Transcript : Axogen, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-11-2025 02 - MarketScreener
Axogen, Inc. Reports 2024 Fourth Quarter and Full-Year Financial Results - The Globe and Mail
AxoGen, Inc. (NASDAQ:AXGN) Sees Significant Increase in Short Interest - Defense World
Finanzdaten der Axogen Inc-Aktie (AXGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):